healthcare
FinanceBridgepoint and Triton Pull Out of Buyout Talks for UK's Spire Healthcare
Analysis-TrumpRx Lists Many Medicines at Prices Higher Than Paid in UK
Pope Leo Calls Universal Healthcare a 'moral Imperative'
Novo Nordisk Strikes Deal for Hims to Sell Wegovy and Ozempic, Drops Lawsuit
Roche Shares Drop as Oral Breast Cancer Drug Fails in Trial
Date: March 9, 2026
FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising drug candidate giredestrant against a common form of breast...
Novo and Hims Resolve Dispute, Will Sell Obesity Drugs Together, Bloomberg News Reports
Date: March 7, 2026
March 6 (Reuters) - Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal...
Fda Tells uniQure Early Trial Data Insufficient for Brain Disorder Therapy Filing
Date: March 2, 2026
March 2 (Reuters) - UniQure said on Monday the U.S. health regulator has informed the company that data from an early- to mid-stage trial of its gene therapy for a brain disorder would not support a...
Dancing Robots Bring Support, Company to Barcelona Elderly
Date: February 27, 2026
By Alba Ferrer and Victoria Waldersee BARCELONA, Feb 27 (Reuters) - Barcelona resident Irene Veglison had not danced for more than two decades until a robot moved into her home three months ago. The...
EU Regulator Backs Approval for Moderna's Combined Covid and Flu Vaccine
Date: February 27, 2026
By Bhanvi Satija Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to...
Eli Lilly's Weight-Loss Pill Shows Higher Side Effects Than Novo Rival in Diabetes Trial
Date: February 26, 2026
Feb 26 (Reuters) - Eli Lilly on Thursday released new data from a head-to-head trial of its experimental weight-loss pill, orforglipron, and rival Novo Nordisk's oral semaglutide in diabetes patients,...